Furosemide

Product NDC: 68071-2313
11-digit product format: 680712313
Labeler code: 68071
Product ID: 68071-2313_d775c43c-2c40-586b-e053-2a95a90a0b35
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: furosemide
Dosage form: TABLET
Route: ORAL
Labeler: NuCare Pharmaceuticals,Inc.
Application: ANDA076796
Marketing category: ANDA
Marketing start: 2004-03-26
Marketing end: 0000-00-00
Substance: FUROSEMIDE
Active strength: 20 mg/1
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68071-2313		I	Inactivated by FDA		2026-10-12
excluded package	package	68071-2313	68071-2313-3	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68071-2313-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68071-2313-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68071-2313-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68071-2313-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68071-2313-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68071-2313-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68071-2313-3	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68071-2313-3	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68071-2313-3	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A076796-001	FUROSEMIDE	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26
A076796-002	FUROSEMIDE	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26
A076796-003	FUROSEMIDE	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A076796-001	AB
A076796-002	AB
A076796-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A076796-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076796-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076796-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076796-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076796-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076796-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076796-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076796-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076796-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-001	AB	1	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68071-2313-3	2025-01-30	C162847	48780-1	d6a99b3a-010a-a426-e053-dadaa90af4c2	FUROSEMIDE TABLETS, USP 20, 40, and 80 mg
68071-2313-3	2022-02-07	C162847	48780-1	d6a99b3a-010a-a426-e053-dadaa90af4c2	FUROSEMIDE TABLETS, USP 20, 40, and 80 mg
68071-2313-3	2022-01-28	C162847	48780-1	d6a99b3a-010a-a426-e053-dadaa90af4c2	FUROSEMIDE TABLETS, USP 20, 40, and 80 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68071-2313-3	Furosemide	30 in 1 BOTTLE, PLASTIC	TABLET	30		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68071-2313	FUROSEMIDE TABLET [NUCARE PHARMACEUTICALS,INC.]	2	Legacy NDC, 1 package rows	20220208_b623c3b3-3e25-67f0-e053-2a95a90a297c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 30 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	d07ff11c-c1ab-41e6-a455-f2b89340106e	2024-02-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	a5e94bf3-bb18-4c81-98af-8c1cb7e00496	2024-02-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	020bc039-9e99-4895-96f8-0c6a556d3e67	2023-10-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	01a5f094-b473-4e46-9e61-69d5ec6dd766	2023-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	6820724c-1ca5-451c-9d2b-2d38e60036f5	2023-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	440aaaed-47df-4bb5-8b41-2c8056893679	2023-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	15ae6f44-88dd-4455-b1f7-4718c91e7b66	2023-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	3ad12e70-3c2e-44af-bb6b-5762d181c76b	2023-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	6f124d7d-a19d-4de6-8ea4-719a42eb520b	2022-03-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	1d2733ac-6fa6-44d1-96d4-f1a698045ad2	2018-04-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310429	furosemide 20 MG Oral Tablet	PSN	b623c3b3-3e25-67f0-e053-2a95a90a297c	2
310429	furosemide 20 MG Oral Tablet	SCD	b623c3b3-3e25-67f0-e053-2a95a90a297c	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68071-2313-3	68071231303	30 TABLET in 1 BOTTLE, PLASTIC (68071-2313-3)	30 tablet	2020-12-10	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FUROSEMIDE TABLETS, USP 20, 40, and 80 mg	NuCare Pharmaceuticals,Inc.	2022-02-07	HUMAN PRESCRIPTION DRUG LABEL	2